Deprecated: Function set_magic_quotes_runtime() is deprecated in /home/xcqte.nl/public_html/textpattern/lib/txplib_db.php on line 14

Warning: Cannot modify header information - headers already sent by (output started at /home/xcqte.nl/public_html/textpattern/lib/txplib_db.php:14) in /home/xcqte.nl/public_html/textpattern/lib/txplib_misc.php on line 1447

Warning: Cannot modify header information - headers already sent by (output started at /home/xcqte.nl/public_html/textpattern/lib/txplib_db.php:14) in /home/xcqte.nl/public_html/textpattern/lib/txplib_misc.php on line 1448

Warning: Cannot modify header information - headers already sent by (output started at /home/xcqte.nl/public_html/textpattern/lib/txplib_db.php:14) in /home/xcqte.nl/public_html/textpattern/publish/rss.php on line 198

Warning: Cannot modify header information - headers already sent by (output started at /home/xcqte.nl/public_html/textpattern/lib/txplib_db.php:14) in /home/xcqte.nl/public_html/textpattern/publish/rss.php on line 199
http://textpattern.com/?v=4.0.4 XCQTE http://xcqte.nl/ mijn pakkende slagzin Fri, 31 Aug 2007 07:01:03 GMT Edwin Klumper, MD PhD MBA (1959) Manager with a broad experience in the Pharma/Biotech industry. Strong track record in commercial roles. Solid background in medicine and business. Profound knowledge of marketing & sales operations. Significant international experience. Analytical, energetic, trustworthy and result-oriented. Proven capabilities in leadership roles.

  1. 2006 Founder XCQTE Pharma/Biotech Consultancy; start-up
  2. 2005 VP Marketing & Sales Europe NABI; European start-up
  3. 2002 Brand Director Amgen Europe; brand management
  4. 2001 Business Unit Director Amgen UK; turn-around
  5. 1999 Business Unit Director Amgen NL; blockbuster launch
  6. 1997 Marketing Manager Asta Medica; portfolio management
  7. 1995 Medical Director Yew Tree Pharmaceuticals; business development
  8. 1990 Fellow scientist VU Academic Hospital; medical research


External partners

XCQTE collaborates closely with a limited number of carefully selected and highly specialized consultancies that complement each other by geography and/or expertise. You will have access to a highly professional, broad and profound industrial network. To solve complex problems you can rely on integrated solutions of excellent quality.



















]]>
http://xcqte.nl/referenties_en/9/edwin-klumper-md-phd-mba-1959 Sun, 17 Dec 2006 22:49:19 GMT Thomas Jacobs tag:xcqte.nl,2006-12-17:8fe4481a48049e1af40b987717c43534/a7bb09e1c420d95b1798746a71648a61
The ‘unaddressed’ problem There are many good products, smart plans, and motivated people. Yet, reality shows that targets are often being missed. The problem is execution. People have never been taught specifically how to get things done. XCQTE will help you to solve this problem.


The XCQTE approach

An integral approach will tightly link plans, people, and processes. Plans define where to go, people who is going to get us there, and processes how to get there. It sounds simple, but it is hard to put into practice. The XCQTE approach will ensure a seamless transition of plan into action.


The XCQTE attitude

A professional attitude is important to an integral approach: trust, collaboration, candid dialogue, accountability, and follow through. This attitude will lead to a realistic view on issues, transparent decisions, focused plans, commonly shared targets, and clear individual tasks. XCQTE will hold people responsible for a professional attitude.


The ‘flight simulator’ solution

A robust and realistic process will show how to simply solve the problems. Your people will go through all the motions and everybody knows what needs to be done and above all how to get things done! Your teams are ready for success after the XCQTE flight simulator experience.

]]>
http://xcqte.nl/aanpak_en/8/the-unaddressed-problem Sun, 17 Dec 2006 22:48:29 GMT Thomas Jacobs tag:xcqte.nl,2006-12-17:8fe4481a48049e1af40b987717c43534/0ec43aa0c981e33a3026144b34de86f7
Business Development Business Plan

We help you to develop a BP. A solid BP is conditional to manage a company effectively and for investors to participate. A second opinion is also possible.

Valuation of company / portfolio / product

In support of an exit/acquisition or buy/sell decision of product(s) we calculate a NPV based on realistic assumptions and risk management using in-dept market knowledge and experience.

Asset Deals

We give advice about decisions like selling, licensing, or co-promotion. We can also act as an intermediate to search for the right partners and to close deals.

Product-Market Strategy

We develop a feasible strategy including a P&L. Decisions must be made about the primary market and main indication, competitive position, pricing and reimbursement, M&S organization, distribution, European launch, just to name a few.

Project Management

We provide management support to drive commercial projects. If required, we can help to set up a legal entity, establish a European office, build commercial operations, and launch a new product.


Medical Affairs

Clinical Development Plan

We will develop a CDP aligned with your commercial strategy. Integration of science and business is required to take decisions about main indication and primary market. Also important is to fix the budget, registration strategy, health economics, protocol design, selection of EU centers and opinion leaders, to name a few.

Clinical Project Management

We provide management support to drive clinical projects. If required, we help setting up a clinical department, outsourcing, CRO selection and monitoring, and investigator meetings.

Medical Marketing

Early adoption and eraly access programs may add considerable value. Some examples are compassionate use, “sell” science through courses, round tables, congresses and medical reps.


Questions?

XCQTE aims for tailor-made services. Are you looking for specific services or want more information about services, please contact us for free advice. Talking costs nothing, but may produce big results.

]]>
http://xcqte.nl/services_en/7/business-development Sun, 17 Dec 2006 22:48:02 GMT Thomas Jacobs tag:xcqte.nl,2006-12-17:8fe4481a48049e1af40b987717c43534/52df7988fabda036e3565957fb82a127
Building bridges…

XCQTE builds bridges between science en business. We support and accelerate commercialization of biotech innovations. Main activities are business development and medical affairs. Our approach is progressive, pragmatic, and always goal oriented. XCQTE aims to add value by helping biotechs to make new therapies available to patients fast.

Dynamics in the pharmaceutical industry have changed radically. The biotech revolution is full steam ahead and maturing fast. Ever since the genome has been unraveled, many new targets and pathways have been identified. New technologies are capable of screening billions of compounds fast and selecting the most favorable lead compounds. The number of innovations and biotech companies are growing fast. XCQTE has to its disposal an extensive biotech network, knowledge and experience.

Innovation drives pharma. New products gain value as their chances to successful market introduction increase. However, biotechs are faced with increasing competition. Smaller markets for selected patient groups are created by developing drugs with more specific mechanisms of action. Often, several new drugs are being launched in the same market simultaneously. Price and market share of innovative drugs have never been so much under pressure in history before. To date, speed and quality in product development are more important than ever before. XCQTE supports biotechs with commercialization of new products through bridging business and science.



















]]>
http://xcqte.nl/home_en/6/who-is-x Sun, 17 Dec 2006 22:47:33 GMT Thomas Jacobs tag:xcqte.nl,2006-12-17:8fe4481a48049e1af40b987717c43534/40409b062c063441af4c7ffe7ae5118f
Edwin Klumper, MD PhD MBA (1959) Manager met ruime ervaring in de Farma/Biotech industrie. Een stevige trackrecord in commerciele rollen. Solide medische en business achtergrond. Diepgaande kennis van marketing & sales processen. Significante internationale ervaring. Analytisch, gedreven, betrouwbaar en resultaatgericht. Bewezen capaciteit om mensen en teams te leiden.

  1. 2006 Oprichter XCQTE Pharma/Biotech Consultancy; start-up
  2. 2005 VP Marketing & Sales Europe NABI; European start-up
  3. 2002 Brand Director Amgen Europe; brand management
  4. 2001 Business Unit Director Amgen UK; turn-around
  5. 1999 Business Unit Director Amgen NL; blockbuster launch
  6. 1997 Marketing Manager Asta Medica; portfolio management
  7. 1995 Medical Director Yew Tree Pharmaceuticals; business development
  8. 1990 Fellow scientist VU Academic Hospital; medical research


Externe partners

XCQTE werkt nauw samen met een beperkt aantal zorgvuldig geslecteerde en hoog gespecialiseerde consultancies die elkaar aanvullen door geografie en/of expertise. U hebt toegang tot een zeer professioneel, breed en diepgaand industrieel netwerk. Voor complexe problemen kunt u vertrouwen op geintegreerde oplossingen van uitmuntende kwaliteit.




















]]>
http://xcqte.nl/referenties/5/edwin-klumper-md-phd-mba-1959 Sun, 17 Dec 2006 22:45:48 GMT Thomas Jacobs tag:xcqte.nl,2006-12-17:8fe4481a48049e1af40b987717c43534/b347fbb39c2880b9c49c98a4b41193c2